Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
RARE

Ultragenyx

$71.81

-7.64 (-9.62%)

07:39
08/06/18
08/06
07:39
08/06/18
07:39
Recommendations
Ultragenyx analyst commentary at Wedbush »

Ultragenyx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

RARE

Ultragenyx

$79.45

0.12 (0.15%)

07:03
08/03/18
08/03
07:03
08/03/18
07:03
Recommendations
Ultragenyx analyst commentary at Barclays »

Ultragenyx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

RARE

Ultragenyx

$79.45

0.12 (0.15%)

05:32
08/03/18
08/03
05:32
08/03/18
05:32
Recommendations
Ultragenyx analyst commentary at Piper Jaffray »

Ultragenyx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

RARE

Ultragenyx

$79.45

0.12 (0.15%)

16:22
08/02/18
08/02
16:22
08/02/18
16:22
Earnings
Ultragenyx reports Q2 EPS ($1.06), consensus ($2.09) »

The loss for the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 12

    Sep

RARE

Ultragenyx

$81.26

1.98 (2.50%)

08:38
07/26/18
07/26
08:38
07/26/18
08:38
Hot Stocks
Ultragenyx announces first patient dosed in Phase 1/2 study of DTX401 »

Ultragenyx Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

Over a month ago
RARE

Ultragenyx

$84.32

-0.23 (-0.27%)

09:31
07/17/18
07/17
09:31
07/17/18
09:31
Recommendations
Ultragenyx analyst commentary at Leerink »

Ultragenyx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

RARE

Ultragenyx

$76.13

0.24 (0.32%)

09:09
06/29/18
06/29
09:09
06/29/18
09:09
Hot Stocks
Ultragenyx receives positive CHMP opinion for Mepsevii »

Ultragenyx Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

RARE

Ultragenyx

$85.28

4.58 (5.68%)

07:55
06/21/18
06/21
07:55
06/21/18
07:55
Downgrade
Ultragenyx rating change  »

Ultragenyx downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

RARE

Ultragenyx

$85.28

4.58 (5.68%)

05:57
06/21/18
06/21
05:57
06/21/18
05:57
Downgrade
Ultragenyx rating change at Credit Suisse »

Ultragenyx downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

AIMT

Aimmune

$30.99

-0.01 (-0.03%)

, RARE

Ultragenyx

$79.72

0.18 (0.23%)

08:24
06/12/18
06/12
08:24
06/12/18
08:24
Recommendations
Aimmune, Ultragenyx analyst commentary at JMP Securities »

JMP Securities continues…

AIMT

Aimmune

$30.99

-0.01 (-0.03%)

RARE

Ultragenyx

$79.72

0.18 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.